Skip to main content
Premium Trial:

Request an Annual Quote

Strata Biosciences Wins Research Grant From NCI

Premium

ALAMEDA, Calif.--Strata Biosciences here was awarded a $100,000 Small Business Innovation Research grant from the US National Cancer Institute for a six-month functional genomics technology innovation project. Strata is a privately funded functional genomics company implementing proprietary high-throughput gene knockout technologies for gene discovery, drug target identification, and validation.

According to Douglas Lane, president and chief executive officer, Strata's technology has the capacity to validate and target genes at a rate exceeding industry standards. "These proprietary tools accelerate the most critical step of conventional pharmaceutical innovation, resulting in cost-effective drug discovery," he said.

Combining molecular biology, high-throughput screening, bioinformatics, and cell-based models, Strata's efforts are focused on research in the areas of prostate, breast, and ovarian cancer, and immune regulation.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.